118 related articles for article (PubMed ID: 3006475)
1. Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma.
Erhardt K; Auer G; Folin A; Silfverswärd C; Skoog L
Am J Clin Oncol; 1986 Feb; 9(1):83-9. PubMed ID: 3006475
[TBL] [Abstract][Full Text] [Related]
2. Digital cell image analysis of Feulgen-stained nuclei from human papillary, medullary, colloid, lobular and comedocarcinomas of the breast.
Zandona C; Budel V; Larsimont D; Petein M; Gasperin P; Pasteels JL; Kiss R
Anticancer Res; 1994; 14(5B):2173-82. PubMed ID: 7530931
[TBL] [Abstract][Full Text] [Related]
3. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.
Domagala W; Harezga B; Szadowska A; Markiewski M; Weber K; Osborn M
Am J Pathol; 1993 Mar; 142(3):669-74. PubMed ID: 8384406
[TBL] [Abstract][Full Text] [Related]
4. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK; Nair S
Int J Mol Med; 2001 Aug; 8(2):193-8. PubMed ID: 11445874
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of different histologic types of breast cancer.
Li CI; Uribe DJ; Daling JR
Br J Cancer; 2005 Oct; 93(9):1046-52. PubMed ID: 16175185
[TBL] [Abstract][Full Text] [Related]
6. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
7. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
8. Cell kinetics of histologic variants of in situ breast carcinoma.
Meyer JS
Breast Cancer Res Treat; 1986; 7(3):171-80. PubMed ID: 3022849
[TBL] [Abstract][Full Text] [Related]
9. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer.
Silfverswärd C; Gustafsson JA; Gustafsson SA; Humla S; Nordenskjöld B; Wallgren A; Wrange O
Cancer; 1980 Apr; 45(8):2001-5. PubMed ID: 6245787
[TBL] [Abstract][Full Text] [Related]
11. Nuclear DNA content in mammary carcinomas in women aged 35 or younger.
von Rosen A; Fallenius A; Sundelin B; Auer G
Am J Clin Oncol; 1986 Oct; 9(5):382-6. PubMed ID: 3022573
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis.
Reiner A; Reiner G; Spona J; Schemper M; Holzner JH
Cancer; 1988 Mar; 61(6):1149-54. PubMed ID: 2830006
[TBL] [Abstract][Full Text] [Related]
13. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
[TBL] [Abstract][Full Text] [Related]
14. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
15. Assessment of malignancy potential in mammary carcinoma in elderly patients.
von Rosen A; Gardelin A; Auer G
Am J Clin Oncol; 1987 Feb; 10(1):61-4. PubMed ID: 3825995
[TBL] [Abstract][Full Text] [Related]
16. Limited prognostic value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer.
Uyterlinde AM; Schipper NW; Baak JP; Peterse H; Matze E
Am J Clin Pathol; 1988 Mar; 89(3):301-7. PubMed ID: 2831704
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
18. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis].
Ricevuti G; Barni S
Arch Sci Med (Torino); 1983; 140(4):393-400. PubMed ID: 6201153
[TBL] [Abstract][Full Text] [Related]
19. Correlation between histopathologic features and estrogen receptor status in primary breast cancer.
Mantouvalos H; Makrygiannakis A; Metallinos C; Yianniou A; Gouskos A
Int J Gynaecol Obstet; 1984 Jun; 22(3):177-9. PubMed ID: 6148273
[TBL] [Abstract][Full Text] [Related]
20. Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer.
Antoniades K; Spector H
Am J Clin Pathol; 1979 May; 71(5):497-503. PubMed ID: 222129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
